LOWI: How Dutch Research Misconduct Review Works

LOWI — the Landelijk Orgaan Wetenschappelijke Integriteit, or Netherlands Board on Research Integrity — is the national body that gives independent second opinions on research-misconduct rulings made by Dutch research institutions. It does not investigate misconduct allegations itself, and it does not issue binding findings. Instead, once a Dutch university, university medical center, or other affiliated institution has already reached a provisional ruling on a research-integrity complaint, either the person who filed the complaint or the researcher accused can ask LOWI to review that ruling and issue independent advice back to the institution’s executive board.

This structure — institution-first, national-appellate-advisory-second — is a genuinely different model from the one most research-administration audiences outside the Netherlands are used to, where a single federal body such as the US Office of Research Integrity (ORI) can itself investigate and issue findings for federally funded biomedical research. Understanding how LOWI actually works matters for anyone administering research at a Dutch institution, any international collaborator on a project with a Dutch partner, or anyone building a cross-national picture of how research misconduct is governed outside the US.

Where LOWI Sits in the Dutch Research Integrity System

The Netherlands does not have a single federal agency with statutory authority to investigate and rule on research misconduct the way ORI does for PHS-funded research in the US. Instead, responsibility for handling a complaint sits first with the institution itself:

Most Dutch universities and university medical centers appoint a confidentiality advisor (vertrouwenspersoon) or integrity officer a researcher or staff member can approach informally about a concern.
Where a concern escalates into a formal complaint, the institution’s own research integrity committee investigates it and reports to the institution’s executive board.
The board issues a provisional ruling on whether research misconduct occurred.

LOWI enters only at this point, and only if invited to by one of the parties. It is a second-opinion body, not a first-instance investigator, and its jurisdiction is limited to institutions affiliated with it — per LOWI’s own account of its structure, it currently has 19 member organizations spanning Dutch universities, university medical centers, and major public research funders and academies.

Legal Status and Governance

LOWI was established in May 2003, jointly founded by the Royal Netherlands Academy of Arts and Sciences (KNAW), the Dutch Research Council (NWO), and the association of Dutch universities then known as VSNU (renamed Universities of the Netherlands, UNL, in November 2021). In 2019, LOWI became an independent non-profit association in its own right, a change explicitly intended to underline its independence from any single founding body.

LOWI’s panel is composed of nine members drawn from a range of academic disciplines; the chair is preferably someone with legal expertise. Cases are typically heard by a smaller panel drawn from this membership, not the full board.

The Netherlands Code of Conduct for Research Integrity

LOWI’s advisory opinions are issued against the substantive standard set out in the Netherlands Code of Conduct for Research Integrity (most recently revised in 2018, replacing earlier 2004 and 2014 versions), jointly adopted by UNL, NWO, KNAW, and other Dutch research organizations. The Code:

Defines research misconduct as a serious violation of the standards of good research practice it sets out, with fabrication, falsification, and plagiarism (FFP) given as the clearest examples — the same core triad that anchors most national definitions internationally, including ORI’s.
Explicitly distinguishes formal research misconduct from lesser questionable research practices and minor shortcomings, a three-tier severity framework that is more explicit in the Dutch Code than in some comparable national codes.
Applies to all research conducted under the auspices of an affiliated Dutch institution, not only publicly funded or biomedical research — a broader scope than the PHS-funding trigger that defines ORI’s own jurisdiction in the US.

Institutions translate the Code into their own procedures and regulations; LOWI checks whether an institution’s provisional ruling was reached correctly and reasonably against that shared national standard, rather than applying a rule of its own.

How the Second-Opinion Procedure Actually Works

The process runs on a defined, fairly fast timeline compared to many institutional or federal misconduct processes elsewhere:

Institutional provisional ruling. The affiliated institution’s executive board issues a provisional decision on the complaint, based on its own committee’s investigation.
Petition to LOWI within six weeks. Either the complainant or the respondent (the researcher accused) — not the institution itself — may petition LOWI for a second opinion. The petition must reach LOWI within six weeks of the date of the institution’s provisional ruling.
Admissibility check. LOWI first decides whether the petition is eligible for processing at all — for example, a petition submitted after the six-week window will be declared inadmissible.
Exchange of documents. The parties exchange written submissions and have the opportunity to respond to each other’s positions in writing.
Hearing, if needed. If the written record is not sufficient to assess the facts, LOWI can convene a hearing with the parties involved.
Advisory opinion issued. LOWI aims to issue its second opinion within six weeks of a hearing, or within six weeks of deciding a hearing is not necessary.
Institution’s final ruling. The institution’s executive board then issues its final ruling, taking LOWI’s advisory opinion into account.

Compare this to the process at a US institution receiving PHS funding, walked through in How a Research Misconduct Investigation Actually Works and Institutional vs. Federal Jurisdiction in Research Misconduct Cases: the US model separates institutional inquiry/investigation from a federal oversight body (ORI) that can independently review the institutional record, make its own findings, and impose federal administrative actions. The Dutch model keeps final decision-making authority with the institution throughout — LOWI’s role is confined to advising on whether that decision was properly reached.

Advisory, Not Binding — What That Actually Means in Practice

This is the detail most often misunderstood by anyone approaching the Dutch system with a US or UK mental model already in place: LOWI’s second opinion is formally advisory, not a binding ruling. The institution’s executive board, not LOWI, issues the legally operative final decision on whether research misconduct occurred and what follows from it (correction, retraction requests to journals, personnel action, and so on). LOWI has no independent statutory enforcement power comparable to ORI’s ability to impose federal debarment or require a voluntary exclusion agreement.

In practice, because LOWI’s opinions are public, reasoned, and issued by a national body every affiliated institution has voluntarily agreed to be bound by procedurally, institutions departing from LOWI’s advice without strong justification face real reputational and governance exposure. The system relies on institutional self-regulation backed by peer and public visibility rather than a statutory penalty structure — a soft-law model consistent with how the Netherlands Code of Conduct itself operates as a jointly adopted standard rather than a piece of legislation.

LOWI vs. ORI: Two Structurally Different National Models

Research administrators working across borders benefit from seeing the structural contrast plainly, rather than assuming one country’s process maps onto another’s vocabulary:

Trigger for national involvement. ORI can become involved once PHS funding is implicated in an allegation, largely independent of what stage the institution’s own process has reached. LOWI can only become involved after an institution has already issued a provisional ruling, and only if a party affirmatively petitions for review.
Authority. ORI’s oversight sits within a US federal regulatory framework (Research Integrity Officer processes under 42 CFR Part 93) and can produce federal findings with real regulatory consequences. LOWI issues advisory opinions with no independent enforcement mechanism of its own.
Scope. ORI’s jurisdiction is scoped to PHS-supported biomedical and behavioral research. The Netherlands Code of Conduct, and by extension LOWI’s frame of reference, applies across all research disciplines conducted at an affiliated Dutch institution, regardless of funding source.
Who can invoke it. An ORI case can originate with a whistleblower complaint routed through an institutional RIO. A LOWI case can only be initiated by the complainant or the respondent, after the fact, as a check on an institutional decision already made.

Neither structure is objectively stronger; they reflect different national traditions of research governance — a federal-statutory model in the US versus institutional self-regulation checked by a jointly established national peer body in the Netherlands. The European Code of Conduct for Research Integrity (ALLEA) sits above both as a continent-wide reference framework that national codes like the Dutch one, and institutional policy more broadly, are expected to align with, without itself creating a supranational enforcement body.

Transparency: LOWI’s Published Advisory Opinions

LOWI publishes its advisory opinions, generally anonymized to protect the parties’ identities during and after proceedings. This published-opinion practice functions similarly, in spirit, to how ORI publishes case summaries in the US Federal Register once a finding is closed — both create a public, precedent-forming record that shapes how future institutional committees and complainants understand what counts as misconduct in practice, beyond the bare text of the governing code.

Frequently Asked Questions

Who can request a LOWI second opinion?

Only the complainant or the respondent in an institutional research-misconduct case — not the institution itself, and not a third party. The petition must be submitted within six weeks of the institution’s provisional ruling.

Is LOWI’s advice legally binding on the institution?

No. LOWI’s second opinion is formally advisory. The institution’s executive board issues the final, legally operative ruling, taking LOWI’s opinion into account. There is no independent enforcement mechanism attached to a LOWI opinion itself.

Does LOWI investigate misconduct allegations directly?

No. LOWI does not conduct first-instance investigations. That responsibility sits with the affiliated institution’s own research integrity committee. LOWI reviews whether the institution’s provisional ruling was properly reached.

How is LOWI different from the US Office of Research Integrity (ORI)?

ORI can investigate and issue federal findings for PHS-funded research, with real regulatory consequences. LOWI is a second-opinion advisory body with no independent enforcement authority, and it can only review a case after an affiliated institution has already reached a provisional ruling. See the comparison above for the full structural contrast.

What research does the Netherlands Code of Conduct for Research Integrity cover?

It applies to all research conducted under the auspices of an institution affiliated with the Code — across disciplines and funding sources — rather than being limited to a specific funder’s grants, as ORI’s jurisdiction is.

How long does the LOWI process take?

A petition must reach LOWI within six weeks of the institution’s provisional ruling. LOWI then aims to issue its advisory opinion within six weeks of a hearing (or within six weeks of deciding no hearing is needed), on top of whatever time the prior document-exchange stage takes.

LOWI: How the Netherlands’ Research Integrity Second-Opinion Process Works